Industry: Chemical & Material
Published Date: 2025-09-10
Pages: 95 Pages
Report ld: 4846711
Request Sample
Customized Report
Pharmaceutical Grade Amino Acid Market Size(US$)

CAGR 2025-2031
1.4%
Market Size,2031
USD 1,252
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Grade Amino Acid market size was US$ 1140 million in 2024 and is forecast to a readjusted size of US$ 1252 million by 2031 with a CAGR of 1.4% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Pharmaceutical Grade Amino Acid market competitiveness, regional economic performance, and supply chain configurations.
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Global key players of Pharmaceutical Grade Amino Acid include Ajinomoto, Evonik, Kyowa Hakko, Meihua Holding Group, Wuxi Jinghai, etc. The top five players hold a share over 64%. Asia is the largest market, and has a share about 48%, followed by North America and Europe with share 23% and 19%, separately. In terms of product type, L-Leucine is the largest segment, occupied for a share of 11%. In terms of application, Active Pharmaceuticals Ingredients (APIs) are the largest field with a share about 57 percent.
The global Pharmaceutical Grade Amino Acid market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Grade Amino Acid market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., L-Arginine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical Intermediates in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pharmaceutical Grade Amino Acid value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade Amino Acid Product Scope
1.2 Pharmaceutical Grade Amino Acid by Type
1.2.1 Global Pharmaceutical Grade Amino Acid Sales by Type (2020 & 2024 & 2031)
1.2.2 L-Leucine
1.2.3 L-Arginine
1.2.4 L-Lysine HCL
1.2.5 L-Phenylalanine
1.2.6 L-Threonine
1.2.7 L-Alanine
1.2.8 L-Isoleucine
1.2.9 L-Histidine
1.2.10 L-Valine
1.3 Pharmaceutical Grade Amino Acid by Application
1.3.1 Global Pharmaceutical Grade Amino Acid Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Active Pharmaceuticals Ingredients (APIs)
1.3.3 Pharmaceutical Intermediates
1.3.4 Cell Culture Media Ingredients
1.3.5 Pharmaceutical Excipients
1.3.6 Medical Food
1.3.7 Others
1.4 Global Pharmaceutical Grade Amino Acid Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Grade Amino Acid Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Grade Amino Acid Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Grade Amino Acid Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Grade Amino Acid Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Grade Amino Acid Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Grade Amino Acid Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Grade Amino Acid Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Grade Amino Acid Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Grade Amino Acid Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Grade Amino Acid Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pharmaceutical Grade Amino Acid Market Size and Prospective (2020-2031)
2.4.2 Europe Pharmaceutical Grade Amino Acid Market Size and Prospective (2020-2031)
2.4.3 China Pharmaceutical Grade Amino Acid Market Size and Prospective (2020-2031)
2.4.4 Japan Pharmaceutical Grade Amino Acid Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Grade Amino Acid Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Grade Amino Acid Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Grade Amino Acid Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Grade Amino Acid Price by Type (2020-2025)
3.2 Global Pharmaceutical Grade Amino Acid Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Grade Amino Acid Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Grade Amino Acid Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Grade Amino Acid Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Grade Amino Acid Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Grade Amino Acid Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Grade Amino Acid Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Grade Amino Acid Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Grade Amino Acid Price by Application (2020-2025)
4.2 Global Pharmaceutical Grade Amino Acid Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Grade Amino Acid Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Grade Amino Acid Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Grade Amino Acid Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Grade Amino Acid Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Grade Amino Acid Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Grade Amino Acid Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Grade Amino Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Amino Acid as of 2024)
5.4 Global Pharmaceutical Grade Amino Acid Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Grade Amino Acid, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Grade Amino Acid, Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Grade Amino Acid, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Grade Amino Acid Sales by Company
6.1.1.1 North America Pharmaceutical Grade Amino Acid Sales by Company (2020-2025)
6.1.1.2 North America Pharmaceutical Grade Amino Acid Revenue by Company (2020-2025)
6.1.2 North America Pharmaceutical Grade Amino Acid Sales Breakdown by Type (2020-2025)
6.1.3 North America Pharmaceutical Grade Amino Acid Sales Breakdown by Application (2020-2025)
6.1.4 North America Pharmaceutical Grade Amino Acid Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Grade Amino Acid Sales by Company
6.2.1.1 Europe Pharmaceutical Grade Amino Acid Sales by Company (2020-2025)
6.2.1.2 Europe Pharmaceutical Grade Amino Acid Revenue by Company (2020-2025)
6.2.2 Europe Pharmaceutical Grade Amino Acid Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pharmaceutical Grade Amino Acid Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pharmaceutical Grade Amino Acid Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Grade Amino Acid Sales by Company
6.3.1.1 China Pharmaceutical Grade Amino Acid Sales by Company (2020-2025)
6.3.1.2 China Pharmaceutical Grade Amino Acid Revenue by Company (2020-2025)
6.3.2 China Pharmaceutical Grade Amino Acid Sales Breakdown by Type (2020-2025)
6.3.3 China Pharmaceutical Grade Amino Acid Sales Breakdown by Application (2020-2025)
6.3.4 China Pharmaceutical Grade Amino Acid Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pharmaceutical Grade Amino Acid Sales by Company
6.4.1.1 Japan Pharmaceutical Grade Amino Acid Sales by Company (2020-2025)
6.4.1.2 Japan Pharmaceutical Grade Amino Acid Revenue by Company (2020-2025)
6.4.2 Japan Pharmaceutical Grade Amino Acid Sales Breakdown by Type (2020-2025)
6.4.3 Japan Pharmaceutical Grade Amino Acid Sales Breakdown by Application (2020-2025)
6.4.4 Japan Pharmaceutical Grade Amino Acid Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Ajinomoto
7.1.1 Ajinomoto Company Information
7.1.2 Ajinomoto Business Overview
7.1.3 Ajinomoto Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Ajinomoto Pharmaceutical Grade Amino Acid Products Offered
7.1.5 Ajinomoto Recent Development
7.2 Evonik
7.2.1 Evonik Company Information
7.2.2 Evonik Business Overview
7.2.3 Evonik Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Evonik Pharmaceutical Grade Amino Acid Products Offered
7.2.5 Evonik Recent Development
7.3 Kyowa Hakko
7.3.1 Kyowa Hakko Company Information
7.3.2 Kyowa Hakko Business Overview
7.3.3 Kyowa Hakko Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Kyowa Hakko Pharmaceutical Grade Amino Acid Products Offered
7.3.5 Kyowa Hakko Recent Development
7.4 AMINO
7.4.1 AMINO Company Information
7.4.2 AMINO Business Overview
7.4.3 AMINO Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.4.4 AMINO Pharmaceutical Grade Amino Acid Products Offered
7.4.5 AMINO Recent Development
7.5 Meihua Holding Group
7.5.1 Meihua Holding Group Company Information
7.5.2 Meihua Holding Group Business Overview
7.5.3 Meihua Holding Group Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Meihua Holding Group Pharmaceutical Grade Amino Acid Products Offered
7.5.5 Meihua Holding Group Recent Development
7.6 Tianjin Tianyao
7.6.1 Tianjin Tianyao Company Information
7.6.2 Tianjin Tianyao Business Overview
7.6.3 Tianjin Tianyao Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Tianjin Tianyao Pharmaceutical Grade Amino Acid Products Offered
7.6.5 Tianjin Tianyao Recent Development
7.7 Jingjing
7.7.1 Jingjing Company Information
7.7.2 Jingjing Business Overview
7.7.3 Jingjing Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Jingjing Pharmaceutical Grade Amino Acid Products Offered
7.7.5 Jingjing Recent Development
7.8 Wuxi Jinghai
7.8.1 Wuxi Jinghai Company Information
7.8.2 Wuxi Jinghai Business Overview
7.8.3 Wuxi Jinghai Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Wuxi Jinghai Pharmaceutical Grade Amino Acid Products Offered
7.8.5 Wuxi Jinghai Recent Development
7.9 Jiahe Biotech
7.9.1 Jiahe Biotech Company Information
7.9.2 Jiahe Biotech Business Overview
7.9.3 Jiahe Biotech Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Jiahe Biotech Pharmaceutical Grade Amino Acid Products Offered
7.9.5 Jiahe Biotech Recent Development
7.10 Hubei Bafeng
7.10.1 Hubei Bafeng Company Information
7.10.2 Hubei Bafeng Business Overview
7.10.3 Hubei Bafeng Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Hubei Bafeng Pharmaceutical Grade Amino Acid Products Offered
7.10.5 Hubei Bafeng Recent Development
7.11 Grand Hoyo
7.11.1 Grand Hoyo Company Information
7.11.2 Grand Hoyo Business Overview
7.11.3 Grand Hoyo Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Grand Hoyo Pharmaceutical Grade Amino Acid Products Offered
7.11.5 Grand Hoyo Recent Development
7.12 Yichang Sanxia Proudin
7.12.1 Yichang Sanxia Proudin Company Information
7.12.2 Yichang Sanxia Proudin Business Overview
7.12.3 Yichang Sanxia Proudin Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Yichang Sanxia Proudin Pharmaceutical Grade Amino Acid Products Offered
7.12.5 Yichang Sanxia Proudin Recent Development
7.13 Shine Star
7.13.1 Shine Star Company Information
7.13.2 Shine Star Business Overview
7.13.3 Shine Star Pharmaceutical Grade Amino Acid Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Shine Star Pharmaceutical Grade Amino Acid Products Offered
7.13.5 Shine Star Recent Development
8 Pharmaceutical Grade Amino Acid Manufacturing Cost Analysis
8.1 Pharmaceutical Grade Amino Acid Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Grade Amino Acid
8.4 Pharmaceutical Grade Amino Acid Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Grade Amino Acid Distributors List
9.3 Pharmaceutical Grade Amino Acid Customers
10 Pharmaceutical Grade Amino Acid Market Dynamics
10.1 Pharmaceutical Grade Amino Acid Industry Trends
10.2 Pharmaceutical Grade Amino Acid Market Drivers
10.3 Pharmaceutical Grade Amino Acid Market Challenges
10.4 Pharmaceutical Grade Amino Acid Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Grade Amino Acid market size was US$ 1154 million in 2025 and is forecast to reach a readjusted size of US$ 1267 million by 2032 with a CAGR of 1.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 92
USD 4250.00
(Single User License)
The global Pharmaceutical Grade Amino Acid market was valued at US$ 1154 million in 2025 and is anticipated to reach US$ 1267 million by 2032, at a CAGR of 1.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 139
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade Amino Acid was estimated to be worth US$ 1154 million in 2025 and is projected to reach US$ 1267 million, growing at a CAGR of 1.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 114
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Amino Acid market is projected to grow from US$ 1140 million in 2024 to US$ 1252 million by 2031, at a CAGR of 1.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 151
USD 4900.00
(Single User License)
In 2024, the global market size of Pharmaceutical Grade Amino Acid was estimated to be worth US$ 1140 million and is forecast to reach approximately US$ 1252 million by 2031 with a CAGR of 1.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 146
USD 5900.00
(Single User License)
The global market for Pharmaceutical Grade Amino Acid was estimated to be worth US$ 1140 million in 2024 and is forecast to a readjusted size of US$ 1252 million by 2031 with a CAGR of 1.4% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 123
USD 3950.00
(Single User License)
The global market for Pharmaceutical Grade Amino Acid was valued at US$ 1140 million in the year 2024 and is projected to reach a revised size of US$ 1252 million by 2031, growing at a CAGR of 1.4% during the forecast period.
Published Date: 2025-01-18
Pages: 96
USD 2900.00
(Single User License)
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Published Date: 2024-05-15
Pages: 103
USD 2900.00
(Single User License)
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Published Date: 2024-05-15
Pages: 124
USD 4350.00
(Single User License)
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Published Date: 2024-05-15
Pages: 120
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Amino Acid market size was US$ 1154 million in 2025 and is forecast to reach a readjusted size of US$ 1267 million by 2032 with a CAGR of 1.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 92
The global Pharmaceutical Grade Amino Acid market was valued at US$ 1154 million in 2025 and is anticipated to reach US$ 1267 million by 2032, at a CAGR of 1.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 139
The global market for Pharmaceutical Grade Amino Acid was estimated to be worth US$ 1154 million in 2025 and is projected to reach US$ 1267 million, growing at a CAGR of 1.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 114
The global Pharmaceutical Grade Amino Acid market is projected to grow from US$ 1140 million in 2024 to US$ 1252 million by 2031, at a CAGR of 1.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 151
In 2024, the global market size of Pharmaceutical Grade Amino Acid was estimated to be worth US$ 1140 million and is forecast to reach approximately US$ 1252 million by 2031 with a CAGR of 1.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 146
The global market for Pharmaceutical Grade Amino Acid was estimated to be worth US$ 1140 million in 2024 and is forecast to a readjusted size of US$ 1252 million by 2031 with a CAGR of 1.4% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 123
The global market for Pharmaceutical Grade Amino Acid was valued at US$ 1140 million in the year 2024 and is projected to reach a revised size of US$ 1252 million by 2031, growing at a CAGR of 1.4% during the forecast period.
Published: 2025-01-18
Pages: 96
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Published: 2024-05-15
Pages: 103
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Published: 2024-05-15
Pages: 124
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Published: 2024-05-15
Pages: 120
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now